Gut Microbes May Up PD-1 Inhibitor Response
- PMID: 28336551
- DOI: 10.1158/2159-8290.CD-NB2017-039
Gut Microbes May Up PD-1 Inhibitor Response
Abstract
Confirming the results of animal studies, new research shows that the composition of patients' microbiome influences their response to checkpoint inhibitors. Patients with melanoma who benefit from PD-1 inhibitors carry a greater variety of species and higher numbers of microbes in the Clostridiales group. Increased abundance of certain bacteria in this group also correlated with higher numbers of CD8+ T cells in patients' tumors.
©2017 American Association for Cancer Research.
Comment on
-
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.Science. 2015 Nov 27;350(6264):1079-84. doi: 10.1126/science.aad1329. Epub 2015 Nov 5. Science. 2015. PMID: 26541610 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
